Medicalgorithmics has advanced the integration process with newly signed clients. Accelerated integration drives July revenue growth – up 33% YoY
Medicalgorithmics, a Warsaw Stock Exchange-listed leader in cardiac diagnostics software, has accelerated the onboarding of newly acquired clients. By the end of July, the company had completed 28% of the integration process for clients acquired in 2025 (4 out of 14). The activation of new clients – including a European IDTF (Independent Diagnostic Testing Facility) – contributed to a 33% year-over-year increase in the company’s July revenue. These preliminary results further confirm that Medicalgorithmics has entered a phase of dynamic growth, driven by record demand and increasing sales of its proprietary AI-based diagnostic software.